No association between AKT1 polymorphism and schizophrenia: A case-control study in a Korean population and a meta-analysis

Neuroscience Research

Volumn 66, Issue 3, 2010, Pages 238-245

  Lee, Kyu Young ^a   Joo, Eun Jeong ^a   Jeong, Seong Hoon ^b   Kang, Ung Gu ^c   Roh, Myoung Sun ^c   Kim, Se Hyun ^c   Song, Joo Yun ^c   Hwang, Jae Yeon ^d   Kim, Su Gyeong ^e   Lee, Namyoung ^c   Ahn, Yong Min ^c   Kim, Yong Sik ^c  

^a Eulji General Hospital   (South Korea)

^b Department of Internal Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Eunhye Mental Health Hospital   (South Korea)

^e Kilian Keaney Emotion Behavior Research Institute   (South Korea)

Author keywords

AKT1; Association; Korean; Meta analysis; Polymorphism; Schizophrenia

Indexed keywords

ONCOPROTEIN; PROTEIN AKT1; UNCLASSIFIED DRUG; V AKT MURINE THYMOMA VIRAL ONCOGENE HOMOLOG 1;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; KOREA; LINKAGE DISEQUILIBRIUM; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; SCHIZOPHRENIA;

EID: 77049101392     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.11.005     Document Type: Article

References (39)

1. Ahn Y.M., Seo M.S., Kim S.H., Kim Y., Yoon S.C., Juhnn Y.S., Kim Y.S. Increased phosphorylation of Ser473-Akt, Ser9-GSK-3beta and Ser133-CREB in the rat frontal cortex after MK-801 intraperitoneal injection. Int. J. Neuropsychopharmacol. 2005, 8:607-613.
2. Alimohamad H., Rajakumar N., Seah Y.H., Rushlow W. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol. Psychiatry 2005, 57:533-542.
3. Alimohamad H., Sutton L., Mouyal J., Rajakumar N., Rushlow W.J. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. J. Neurochem. 2005, 95:513-525.
4. Arguello P.A., Gogos J.A. A signaling pathway AKTing up in schizophrenia. J. Clin. Invest. 2008, 118:2018-2021.
5. Bajestan S.N., Sabouri A.H., Nakamura M., Takashima H., Keikhaee M.R., Behdani F., Fayyazi M.R., Sargolzaee M.R., Bajestan M.N., Sabouri Z., Khayami E., Haghighi S., Hashemi S.B., Eiraku N., Tufani H., Najmabadi H., Arimura K., Sano A., Osame M. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:383-386.
6. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
7. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
8. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., Borrelli E., Caron M.G. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J. Neurosci. 2007, 27:881-885.
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 2003, 25:115-121.
10. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 2004, 36:131-137.
11. Ide M., Ohnishi T., Murayama M., Matsumoto I., Yamada K., Iwayama Y., Dedova I., Toyota T., Asada T., Takashima A., Yoshikawa T. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J. Neurochem. 2006, 99:277-287.
12. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ozaki N. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry 2004, 56:698-700.
13. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshiya Y., Sekine Y., Iyo M., Harano M., Komiyama T., Yamada M., Sora I., Ujike H., Inada T., Ozaki N. Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. Int. J. Neuropsychopharmacol. 2006, 9:77-81.
14. Joo E.J., Joo Y.H., Hong J.P., Hwang S., Maeng S.J., Han J.H., Yang B.H., Lee Y.S., Kim Y.S. Korean version of the diagnostic interview for genetic studies: validity and reliability. Compr. Psychiatry 2004, 45:225-229.
15. Kang U.G., Seo M.S., Roh M.S., Kim Y., Yoon S.C., Kim Y.S. The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett. 2004, 560:115-119.
16. Liu Y.L., Fann C.S., Liu C.M., Wu J.Y., Hung S.I., Chan H.Y., Chen J.J., Pan C.C., Liu S.K., Hsieh M.H., Hwang T.J., Ouyang W.C., Chen C.Y., Lin J.J., Chou F.H., Chueh C.M., Liu W.M., Tsuang M.M., Faraone S.V., Tsuang M.T., Chen W.J., Hwu H.G. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr. Genet. 2006, 16:39-41.
17. Liu Y.C., Huang C.L., Wu P.L., Chang Y.C., Huang C.H., Lane H.Y. Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia. J. Psychopharmacol. 2008, July, (Epub ahead of print).
18. Need A.C., Ge D., Weale M.E., Maia J., Feng S., Heinzen E.L., Shianna K.V., Yoon W., Kasperaviciūte D., Gennarelli M., Strittmatter W.J., Bonvicini C., Rossi G., Jayathilake K., Cola P.A., McEvoy J.P., Keefe R.S., Fisher E.M., St Jean P.L., Giegling I., Hartmann A.M., Möller H.J., Ruppert A., Fraser G., Crombie C., Middleton L.T., St Clair D., Roses A.D., Muglia P., Francks C., Rujescu D., Meltzer H.Y., Goldstein D.B. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 2009, 5:e1000373.
19. Norton N., Williams H.J., Owen M.J. An update on the genetics of schizophrenia. Curr. Opin. Psychiatry 2006, 19:158-164.
20. Norton N., Williams H.J., Dwyer S., Carroll L., Peirce T., Moskvina V., Segurado R., Nikolov I., Williams N.M., Ikeda M., Iwata N., Owen M.J., O'Donovan M.C. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr. Res. 2007, 93:58-65.
21. Nurnberger J.I.J., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., Severe J.B., Malaspina D., Reich T. Diagnostic interview for genetic studies: rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 1994, 51:849-859.
22. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., Nikolov I., Hamshere M., Carroll L., Georgieva L., Dwyer S., Holmans P., Marchini J.L., Spencer C.C., Howie B., Leung H.T., Hartmann A.M., Möller H.J., Morris D.W., Shi Y., Feng G., Hoffmann P., Propping P., Vasilescu C., Maier W., Rietschel M., Zammit S., Schumacher J., Quinn E.M., Schulze T.G., Williams N.M., Giegling I., Iwata N., Ikeda M., Darvasi A., Shifman S., He L., Duan J., Sanders A.R., Levinson D.F., Gejman P.V., Cichon S., Nöthen M.M., Gill M., Corvin A., Rujescu D., Kirov G., Owen M.J., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Cloninger C.R. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 2008, 40:1053-1055.
23. Ohtsuki T., Inada T., Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol. Psychiatry 2004, 9:981-983.
24. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
25. Roh M.S., Seo M.S., Kim Y., Kim S.H., Jeon W.J., Ahn Y.M., Kang U.G., Juhnn Y.S., Kim Y.S. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp. Mol. Med. 2007, 39:353-360.
26. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 2008, 165:497-506.
27. Schwab S.G., Hoefgen B., Hanses C., Hassenbach M.B., Albus M., Lerer B., Trixler M., Maier W., Wildenauer D.B. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 2005, 58:446-450.
28. Seo M.S., Kim S.H., Ahn Y.M., Kim Y., Jeon W.J., Yoon S.C., Roh M.S., Juhnn Y.S., Kim Y.S. The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex. Int. J. Neuropsychopharmacol. 2007, 10:359-368.
29. Srisurapanont M., Ali R., Marsden J., Sunga A., Wada K., Monteiro M. Psychotic symptoms in methamphetamine psychotic in-patients. Int. J. Neuropsychopharmacol. 2003, 6:347-352.
30. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., Werge T., Pietiläinen O.P., Mors O., Mortensen P.B., Sigurdsson E., Gustafsson O., Nyegaard M., Tuulio-Henriksson A., Ingason A., Hansen T., Suvisaari J., Lonnqvist J., Paunio T., Børglum A.D., Hartmann A., Fink-Jensen A., Nordentoft M., Hougaard D., Norgaard-Pedersen B., Böttcher Y., Olesen J., Breuer R., Möller H.J., Giegling I., Rasmussen H.B., Timm S., Mattheisen M., Bitter I., Réthelyi J.M., Magnusdottir B.B., Sigmundsson T., Olason P., Masson G., Gulcher J.R., Haraldsson M., Fossdal R., Thorgeirsson T.E., Thorsteinsdottir U., Ruggeri M., Tosato S., Franke B., Strengman E., Kiemeney L.A., Melle I., Djurovic S., Abramova L., Kaleda V., Sanjuan J., de Frutos R., Bramon E., Vassos E., Fraser G., Ettinger U., Picchioni M., Walker N., Toulopoulou T., Need A.C., Ge D., Yoon J.L., Shianna K.V., Freimer N.B., Cantor R.M., Murray R., Kong A., Golimbet V., Carracedo A., Arango C., Costas J., Jönsson E.G., Terenius L., Agartz I., Petursson H., Nöthen M.M., Rietschel M., Matthews P.M., Muglia P., Peltonen L., St Clair D., Goldstein D.B., Stefansson K., Collier D.A. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
31. Sullivan P.F. Spurious genetic associations. Biol. Psychiatry 2007, 61:1121-1126.
32. Sutton L.P., Honardoust D., Mouyal J., Rajakumar N., Rushlow W.J. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3. J. Neurochem. 2007, 102:153-169.
33. Tan H.Y., Nicodemus K.K., Chen Q., Li Z., Brooke J.K., Honea R., Kolachana B.S., Straub R.E., Meyer-Lindenberg A., Sei Y., Mattay V.S., Callicott J.H., Weinberger D.R. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J. Clin. Invest. 2008, 118:2200-2208.
34. Thiselton D.L., Vladimirov V.I., Kuo P.H., McClay J., Wormley B., Fanous A., O'Neill F.A., Walsh D., Van den Oord E.J., Kendler K.S., Riley B.P. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol. Psychiatry 2008, 63:449-457.
35. Turunen J.A., Peltonen J.O., Pietilainen O.P., Hennah W., Loukola A., Paunio T., Silander K., Ekelund J., Varilo T., Partonen T., Lonnqvist J., Peltonen L. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr. Res. 2007, 91:27-36.
36. Volz T.J., Fleckenstein A.E., Hanson G.R. Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment. Addiction 2007, 102(Suppl. 1):44-48.
37. Wall J.D., Pritchard J.K. Assessing the performance of the haplotype block model of linkage disequilibrium. Am. J. Hum. Genet. 2003, 73:502-515.
38. Xu M.Q., Xing Q.H., Zheng Y.L., Li S., Gao J.J., He G., Guo T.W., Feng G.Y., Xu F., He L. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J. Clin. Psychiatry 2007, 68:1358-1367.
39. Zaykin D.V., Westfall P.H., Young S.S., Karnoub M.A., Wagner M.J., Ehm M.G. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered. 2002, 53:79-91.